Being alert on a scale and meeting all discharge conditions are different milestones.
What the paper found
Seventy-four patients aged sixty-five to eighty were randomized to remimazolam or dexmedetomidine. All reached MOAA/S five at procedure completion, yet discharge delays were more frequent with dexmedetomidine. Onset and hypotension observations also favored remimazolam.
Limits of the evidence
The selected dental setting and small sample limit uncommon-event estimates. Reaching the highest responsiveness score does not guarantee identical balance, circulation, comfort or cognitive performance. A delayed-discharge result may involve multiple criteria.
Implications for case review
Ask why discharge was delayed rather than assuming continued unconsciousness. For a particular patient, review the documented criterion, drug timing and other care. The trial cannot establish driving readiness or complete capacity from a terminal alertness score alone.
Source and related reading
Source: PMC12625583, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.
Related: A Bromazepam Stability Assay Separated Parent Drug From a Degradation Impurity.
Leave a Reply